| Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ... Nature medicine 10 (2), 145-147, 2004 | 2501 | 2004 |
| AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ... Cancer cell 11 (1), 83-95, 2007 | 2080 | 2007 |
| Normalization of the vasculature for treatment of cancer and other diseases S Goel, DG Duda, L Xu, LL Munn, Y Boucher, D Fukumura, RK Jain Physiological reviews 91 (3), 1071-1121, 2011 | 1684 | 2011 |
| Angiogenesis in brain tumours RK Jain, E Di Tomaso, DG Duda, JS Loeffler, AG Sorensen, TT Batchelor Nature Reviews Neuroscience 8 (8), 610-622, 2007 | 1597 | 2007 |
| Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges D Fukumura, J Kloepper, Z Amoozgar, DG Duda, RK Jain Nature reviews Clinical oncology 15 (5), 325-340, 2018 | 1434 | 2018 |
| Lessons from phase III clinical trials on anti-VEGF therapy for cancer RK Jain, DG Duda, JW Clark, JS Loeffler Nature clinical practice Oncology 3 (1), 24-40, 2006 | 1374 | 2006 |
| Engineering vascularized tissue RK Jain, P Au, J Tam, DG Duda, D Fukumura Nature biotechnology 23 (7), 821-823, 2005 | 991 | 2005 |
| Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy Y Huang, J Yuan, E Righi, WS Kamoun, M Ancukiewicz, J Nezivar, ... Proceedings of the National Academy of Sciences 109 (43), 17561-17566, 2012 | 943 | 2012 |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 794 | 2021 |
| Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ... Cancer discovery 7 (10), 1116-1135, 2017 | 726 | 2017 |
| Biomarkers of response and resistance to antiangiogenic therapy RK Jain, DG Duda, CG Willett, DV Sahani, AX Zhu, JS Loeffler, ... Nature reviews Clinical oncology 6 (6), 327-338, 2009 | 646 | 2009 |
| Malignant cells facilitate lung metastasis by bringing their own soil DG Duda, AMMJ Duyverman, M Kohno, M Snuderl, EJA Steller, ... Proceedings of the National Academy of Sciences 107 (50), 21677-21682, 2010 | 640 | 2010 |
| Vascular normalization as an emerging strategy to enhance cancer immunotherapy Y Huang, S Goel, DG Duda, D Fukumura, RK Jain Cancer research 73 (10), 2943-2948, 2013 | 638 | 2013 |
| Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? RR Ramjiawan, AW Griffioen, DG Duda Angiogenesis 20, 185-204, 2017 | 608 | 2017 |
| HCC and angiogenesis: possible targets and future directions AX Zhu, DG Duda, DV Sahani, RK Jain Nature reviews Clinical oncology 8 (5), 292-301, 2011 | 583 | 2011 |
| Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study CG Willett, DG Duda, E Di Tomaso, Y Boucher, M Ancukiewicz, ... Journal of Clinical Oncology 27 (18), 3020, 2009 | 583 | 2009 |
| Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma TT Batchelor, DG Duda, E di Tomaso, M Ancukiewicz, SR Plotkin, ... Journal of Clinical Oncology 28 (17), 2817, 2010 | 560 | 2010 |
| Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo M Stroh, JP Zimmer, DG Duda, TS Levchenko, KS Cohen, EB Brown, ... Nature medicine 11 (6), 678-682, 2005 | 560 | 2005 |
| Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study AX Zhu, DV Sahani, DG Duda, E di Tomaso, M Ancukiewicz, OA Catalano, ... Journal of clinical oncology 27 (18), 3027, 2009 | 549 | 2009 |
| Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre‐clinical models DAI Fukumura, DG Duda, LL Munn, RK Jain Microcirculation 17 (3), 206-225, 2010 | 524 | 2010 |
